NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,855 | -53.5% | 46,970 | 0.0% | 0.05% | -58.1% |
| Q2 2023 | $87,834 | -49.5% | 46,970 | -95.0% | 0.12% | +6.9% |
| Q1 2023 | $173,791 | -2.7% | 939,412 | 0.0% | 0.12% | +18.4% |
| Q4 2022 | $178,676 | -51.8% | 939,412 | 0.0% | 0.10% | -52.7% |
| Q3 2022 | $371,000 | -62.4% | 939,412 | 0.0% | 0.21% | -58.3% |
| Q2 2022 | $986,000 | -44.2% | 939,412 | 0.0% | 0.50% | -32.9% |
| Q1 2022 | $1,766,000 | -33.1% | 939,412 | 0.0% | 0.74% | -30.0% |
| Q4 2021 | $2,640,000 | – | 939,412 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |